Dialysis: The importance of peritoneal catheter exit-site care

Nature Reviews Nephrology

Volumn 6, Issue 5, 2010, Pages 259-260

  Piraino, Beth ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; GENTAMICIN; PSEUDOMONIC ACID; RIFAMPICIN;

ANTIBIOTIC THERAPY; BACTERIAL COLONIZATION; CLINICAL TRIAL; DRUG EFFICACY; HUMAN; INFECTION PREVENTION; INFECTION RATE; INFECTION RISK; PERITONEAL CATHETER; PERITONITIS; PRIORITY JOURNAL; R FACTOR; SHORT SURVEY; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; UNSPECIFIED SIDE EFFECT;

ADMINISTRATION, TOPICAL; ADOLESCENT; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; CATHETER-RELATED INFECTIONS; CATHETERS, INDWELLING; CHILD; DISINFECTANTS; HUMANS; KIDNEY FAILURE, CHRONIC; MUPIROCIN; PERITONEAL DIALYSIS; PERITONITIS; PSEUDOMONAS INFECTIONS; RISK FACTORS; SKIN CARE; SODIUM HYPOCHLORITE; STAPHYLOCOCCAL INFECTIONS; TREATMENT OUTCOME;

EID: 77951813388     PISSN: 17595061     EISSN: 1759507X     Source Type: Journal    
DOI: 10.1038/nrneph.2010.45     Document Type: Short Survey

References (10)

1. Chua, A. n., Goldstein, s. L., Bell, D. & Brewer, e. D. Topical mupirocin/sodium hypochlorite reduces peritonitis and exit-site infection rates in children. Clin. J. Am. Soc. Nephrol. 4, 1939-1943 (2009).
2. Johnson, D. w. et al. Associations of dialysis modality and infectious mortality in incident dialysis patients in Australia and New Zealand. Am. J. Kidney Dis. 53, 290-297 (2009).
3. Davenport, A. Peritonitis remains the major clinical complication of peritoneal dialysis: the London, UK, peritonitis audit 2002-2003. Perit. Dial. Int. 29, 297-302 (2009).
4. swartz, R., Messana, J., starmann, B., weber. M. & Reynolds, J. Preventing Staphylococcus aureus infection during chronic peritoneal dialysis. J. Am. Soc. Nephrol. 2, 1085-1091 (1991).
5. Gupta, B., Bernardini, J. & Piraino, B. Peritonitis associated with exit site and tunnel infections. Am. J. Kidney Dis. 28, 415-419 (1996).
6. Zimmerman, s. w. et al. Randomized controlled trial of prophylactic rifampin for peritoneal dialysis-related infections. Am. J. Kidney Dis. 18, 225-231 (1991).
7. Bernardini, J., Piraino, B., Holley, J., Johnston, J. R. & Lutes, R. A randomized trial of Staphylococcus aureus prophylaxis in peritoneal dialysis patients: mupirocin calcium ointment 2% applied to the exit site versus cyclic oral rifampin. Am. J. Kidney Dis. 27, 695-700 (1996).
8. Bernardini, J. et al. Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients. J. Am. Soc. Nephrol. 16, 539-545 (2005).
9. Perez-Fontan, M., Rosales, M., Rodriguez-Carmona, A., Falcón, T. G. & valdés, F. Mupirocin resistance after long-term use for Staphylococcus aureus colonization in patients undergoing chronic peritoneal dialysis. Am. J. Kidney Dis. 39, 337-341 (2002).
10. Annigeri, R. et al. emergence of mupirocinresistant Staphylococcus aureus in chronic peritoneal dialysis patients using mupirocin prophylaxis to prevent exit-site infection. Perit. Dial. Int. 21, 554-559 (2001).